A renal nurse working at her desk

Mission, aims and objectives

Renal avatar

The Donal O’Donoghue Renal Research Centre (DRRC) has been established as a legacy of and to honour Professor O’Donoghue’s break-through improvements in services and care for patients with kidney disease.

The DRRC is committed to establishing national and international excellence in translational nephrology research and in the healthcare of patients with kidney disease. The centre takes a multi-disciplinary and multi-professional approach to performing high quality research and translation of discoveries into every day clinical practice aiming to improve all aspects of patient management.

A nurse wearing a face mask working on the dialysis unit at Salford Royal

The DRRC leadership team includes kidney patients to ensure strong links with our service users and to enable co-creation of research that is important for our patients.

The DRRC aims to discover, develop and implement new approaches in our understanding of the epidemiology of kidney disease, and in patient diagnostics, risk prediction and treatment that will save lives and provide excellent care.

The DRRC objectives are:

  • To perform outstanding research using our expertise and knowledge to identify pathways that will improve patient stratification and optimisation of patient care.
  • To establish platforms that will allow efficient and fruitful partnerships and collaborations with academia, industry and pharmaceutical companies.
  • To increase acquisition of charitable research grants with focus on topics that are clinically and scientifically important.
  • To actively support grant applications and funding bids to ensure financial independence, stability, and sustainability of the Centre.
  • To develop a strong and comprehensive patient and public involvement and engagement (PPIE) network which will help guide our priority research themes.
  • To focus on health inequalities with an inclusive approach to engage previously ‘hard to reach’ patient groups in research, so that eventually there will be no barriers based on protected characteristics that bias patient care and outcomes.
Skip to content